Oppenheimer cuts Liquidia stock rating on launch concerns - Investing.com
Yesterday • Google News
Liquidia Technologies Inc (LQDA)
US$ 16.20.37%
Price Chart
Key Statistics
Market Cap
$ 1.46B
P/E Ratio
0.00
Revenue (TTM)
$ 14.14M
Volume
414.24K
52W High
$ 19.41
52W Low
$ 8.26
Dividend Yield
0.00%
Beta
0.24
Technicals
50-Day MA
14.685
200-Day MA
12.5461
52 Week High
19.41
52 Week Low
8.26
About LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPI.
Employees
170
Headquarters
Morrisville, NC
CEO
Dr. Roger A. Jeffs Ph.D.
Latest News
Liquidia (LQDA) Downgraded to Underperform by Oppenheimer | LQDA Stock News - GuruFocus
22 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg